Financials
- Market Capitalization 3.03 B
- Employee 339
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1672 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 31.09 USD | -2.93% | -12.72% | +21.73% | +13.51% | 3.06 B USD | ||
| 1673 | ELVN Enliven Therapeutics, Inc. - Common Stock | 51.75 USD | +0.04% | +2.31% | +21.74% | +150.48% | 3.15 B USD | ||
| 1710 | CLDX Celldex Therapeutics, Inc. - Common Stock | 38.18 USD | +0.03% | -3.95% | +20.40% | +40.16% | 3.00 B USD | ||
| 1758 | IRON Disc Medicine, Inc. - Common Stock | 74.92 USD | -0.12% | -5.20% | +8.49% | +29.19% | 2.86 B USD |
Frequently asked questions about Vera Therapeutics, Inc. - Class A Common Stock
What is the Vera Therapeutics, Inc. - Class A Common Stock stock price today?
The current price of Vera Therapeutics, Inc. - Class A Common Stock (VERA) is 42.2. Over the past 24 hours, the stock has changed by +3.93%. Follow the VERA chart for real-time price dynamics.
What is the stock ticker of Vera Therapeutics, Inc. - Class A Common Stock?
Vera Therapeutics, Inc. - Class A Common Stock trades under the ticker VERA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vera Therapeutics, Inc. - Class A Common Stock stock going up?
VERA has changed by -1.49% over the last week, +22.35% over the last month, and +41.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Vera Therapeutics, Inc. - Class A Common Stock net income for the last quarter?
Vera Therapeutics, Inc. - Class A Common Stock reported net income of -121.03 M for the last quarter. The previous quarter showed -91.1 M, which means net income changed by -32.86%.
How many employees does Vera Therapeutics, Inc. - Class A Common Stock have?
As of the latest available data, Vera Therapeutics, Inc. - Class A Common Stock has 339 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vera Therapeutics, Inc. - Class A Common Stock EBITDA?
Vera Therapeutics, Inc. - Class A Common Stock EBITDA is -125.42 M, and its EBITDA margin is 29.03 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vera Therapeutics, Inc. - Class A Common Stock stock?
You can buy Vera Therapeutics, Inc. - Class A Common Stock (VERA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vera Therapeutics, Inc. - Class A Common Stock stock?
Investing in Vera Therapeutics, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VERA chart and related analysis on metatrader.com as part of your research.